Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 4, 1998, Pages 1083-1088

  Collins, Michael T ^a   Skarulis, Monica C ^b   Bilezikian, John P ^c   Silverberg, Shonni J ^c   Spiegel, Allen M ^b   Marx, Stephen J ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION; FUROSEMIDE; N [1 (3 METHOXYPHENYL)ETHYL] 3 (2 CHLOROPHENYL) 1 AMINOPROPANE; PAMIDRONIC ACID; PARATHYROID HORMONE; PROPYLAMINE; SALCATONIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CASE REPORT; HUMAN; HYDRATION; HYPERCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PARATHYROID CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031763613     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.4.4726     Document Type: Article

References (18)

1. Shane E, Bilezikian JP. 1982 Parathyroid carcinoma: a review of 62 patients. Endocr Rev. 3:218-226.
2. Bilezikian JP. 1993 Management of hypercalcemia. J Clin Endocrinol Metab. 77:1445-1449.
3. 2+ and other ions as extracellular (first) messengers. Physiol Rev. 71:371-411.
4. Brown EM, Broadus AE, Brennan EF, et al. 1979 Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidism. J Clin Endocrinol Metab. 48:604-610.
5. 2+-sensing receptor from the bovine parathyroid. Nature. 366:575-580.
6. Garrett JE, Tamir H, Kifor O, et al. 1995 Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology. 136:5202-5211.
7. Riccardi DJ, Park WS, Lee G, et al. 1995 Cloning and functional expression of a rat kidney extracellular calcium-sensing receptor. Proc Natl Acad Sci USA. 92:131-135.
8. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell. 75:1297-1303.
9. Pearce SHS, Williamson C, Kifor O, et al. 1996 A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med. 335:1115-1122.
10. Fox J, Hadfield S, Petty BA, Nemeth EF. 1993 A first generation calcimimetic compound (NPS R-568) that acts on the parathyroid cell calcium receptor: A novel therapeutic approach for hyperparathyroidism. J Bone Miner Res. 8:S181.
11. Fox J, Hadfield S, Petty BA, Conklin RL, Nemeth EF. 1993 NPS R-568 inhibits parathyroid hormone secretion in hyperparathyroid rats with chronic renal failure. J Am Soc Nephrol. 4:719.
12. Silverberg SJ, Marriott TB, Bone III HG, et al. 1997 Short term inhibition of parathyroid hormone secretion by a calcium receptor agonist in primary hyperparathyroidism. N Engl J Med. 337:1506-1510.
13. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. 1987 Highly sensitive two-site immunoradiometric assay of parathyroid, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 33:1364-1367.
14. 35S]parathyroid hormone in vivo: Influences of alterations in calcium availability and parathyroid status. J Endocrinol. 122:237-245.
15. 2+ on nodule formation in cultured chondrogenic cells. In: Program and Abstracts of the 79th Annual Meeting of The Endocrine Society. Bethesda: The Endocrine Society Press; 103.
16. 2+. J Bone Miner Res. 12(Suppl):295.
17. House MG, Kohlmeier L, Chattopadhyay N, et al. 1997 Expression of extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res. 12:1959-1970.
18. Quarles LD, Hartle JE, Siddhanti SR, et al. 1997 A distinct cation-sensing mechanism in MC3T3-E1 osteoblasts functionally related to the calcium receptor. J Bone Miner Res. 12:393-402.